Clinical Trials Browser

Phase 2 × Lymphohistiocytosis, Hemophagocytic × Lymphoid × Clear all

Lymphohistiocytosis, Hemophagocytic, Lymphoma, Extranodal NK-T-Cell

NCT04405375 2020-05-28

GPED Regimen for Relapsed/Refractory or Advanced ENKTCL

Phase 2 Unknown

29 enrolled

LymphoidMyeloid

Lymphohistiocytosis, Hemophagocytic, Lymphoma, Extranodal NK-T-Cell

NCT00368355 2020-01-21

MOHEL

Phase 2 Completed

46 enrolled 12 charts

LymphoidMyeloidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphohistiocytosis, Hemophagocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01818908 2019-02-15

Trial of DA-EPOCH Regimen for NHL With HLH

Phase 2 Unknown

50 enrolled

LymphoidMyeloid

Lymphoma, Non-Hodgkin, Lymphohistiocytosis, Hemophagocytic

Clinical Trials

Induction Chemotherapy Sequential Sintilimab Combined With Dual Epigenetic Drugs for ENKTL-HLH

GPED Regimen for Relapsed/Refractory or Advanced ENKTCL

MOHEL

Trial of DA-EPOCH Regimen for NHL With HLH